The extracellular matrix in tumor progression and metastasis

JA Eble, S Niland - Clinical & experimental metastasis, 2019 - Springer
The extracellular matrix (ECM) constitutes the scaffold of tissues and organs. It is a complex
network of extracellular proteins, proteoglycans and glycoproteins, which form …

[HTML][HTML] Matrix metalloproteinase collagenolysis in health and disease

S Amar, L Smith, GB Fields - … et Biophysica Acta (BBA)-Molecular Cell …, 2017 - Elsevier
The proteolytic processing of collagen (collagenolysis) is critical in development and
homeostasis, but also contributes to numerous pathologies. Mammalian interstitial …

Matrix metalloproteinases inhibitors in cancer treatment: an updated review (2013–2023)

S Almutairi, HM Kalloush, NA Manoon, SK Bardaweel - Molecules, 2023 - mdpi.com
Matrix metalloproteinases (MMPs) are identifiable members of proteolytic enzymes that can
degrade a wide range of proteins in the extracellular matrix (ECM). MMPs can be …

Key matrix remodeling enzymes: functions and targeting in cancer

Z Piperigkou, K Kyriakopoulou, C Koutsakis… - Cancers, 2021 - mdpi.com
Simple Summary Proteolytic enzymes, such as matrix metalloproteinases, plasminogen
activators and cathepsins, as well as non-proteolytic enzymatic partners, such as …

The role of matrix metalloproteinases in endometriosis: A potential target

J Ke, J Ye, M Li, Z Zhu - Biomolecules, 2021 - mdpi.com
Endometriosis is a condition that is influenced by hormones and involves stroma and glands
being found outside the uterus; there are increases in proliferation, invasion, internal …

Epithelial‐mesenchymal transition in skin cancers: a review

A Hodorogea, A Calinescu, M Antohe… - Analytical cellular …, 2019 - Wiley Online Library
Epithelial‐mesenchymal transition (EMT) is involved in physiologic processes such as
embryogenesis and wound healing. A similar mechanism occurs in some tumors where …

Chimeric antigen receptor (CAR) T cell therapy for metastatic melanoma: challenges and road ahead

T Soltantoyeh, B Akbari, A Karimi… - Cells, 2021 - mdpi.com
Metastatic melanoma is the most aggressive and difficult to treat type of skin cancer, with a
survival rate of less than 10%. Metastatic melanoma has conventionally been considered …

The expanding role of MT1-MMP in cancer progression

AM Knapinska, GB Fields - Pharmaceuticals, 2019 - mdpi.com
For over 20 years, membrane type 1 matrix metalloproteinase (MT1-MMP) has been
recognized as a key component in cancer progression. Initially, the primary roles assigned …

IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment

M Song, J Liang, L Wang, W Li, S Jiang, S Xu… - International …, 2023 - Elsevier
Abstract Interleukin 17A (IL-17A) is a major member of the IL-17 cytokine family and is
produced mainly by T helper 17 (Th17) cells. Other cells such as CD8+ T cells, γδ T cells …

Metals and metastasis: exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents

L Fouani, SV Menezes, M Paulson… - Pharmacological …, 2017 - Elsevier
Metastasis is currently the leading cause of cancer related death and is the most feared and
difficult to treat outcome for cancer patients. This complex process is regulated by a plethora …